Flex Pharma (FLKS) Tops Q4 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Flex Pharma Reports Year End 2016 Financial Results
March 8, 2017 7:00 AM EST
-- IND Submission for FLX-787 On Track for H1 2017 --
--
Phase 2 ALS & CMT Studies with FLX-787 Planned to Initiate This Year --
--
Successful Launch Year for HOTSHOT® Consumer
Brand; Revenue Exceeds Expectations --
Conference Call
Scheduled Today at 8:30 a.m. ET
BOSTON--(BUSINESS WIRE)-- Click to Tweet
... More
